Based on EHR data, the first-time diagnosis of AD was considered the primary outcome, whereas AD-related medication prescriptions, such as donepezil, lecanemab, rivastigmine, aducanumab, memantine, and galantamine, were considered secondary outcomes
However, losing weight can be difficult due to personal reasons and biology, which cant be changed
Diagnostic testing such as optical coherence tomography (OCT), visual field testing, fluorescein angiography, and comprehensive eye examinations provide objective evidence supporting the diagnosis
The MHRA continues to monitor the safety profile of these drugs, and healthcare professionals must consider the full spectrum of potential side effects when prescribing them
Jrmie JoffreJudith Hellman